November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer
Nov 4, 2024, 15:50

Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on X about his recent article published in European Journal of Cancer.

“Updated Survival Outcome of Regorafenib, Ipilimumab, and Nivolumab in Refractory Microsatellite Stable Non-Liver Metastatic Colorectal Cancer: A Phase I Nonrandomized Clinical Trial”

Authors: Annie Xiao, Xiaochen Li, Chongkai Wang, Jian Ye and Marwan Fakih.

marwan-g-fakih-non-liver-metastatic

“Happy to share our updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer – median OS 27.5months”

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared the post adding:

Glad to be practicing in an era of immunotherapy.

REGOIPINIVO was potentially curative in microsatellite stable tumors.

6 patients had ongoing benefit, including 3 who remain cancer-free greater than 18 months after treatment.”

More posts featuring Pashtoon Kasi.

Dr. Pashtoon Kasi is the Medical Director of GI Medical Oncology at City of Hope, Orange County. Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic.

He also served as the Director of Colon Cancer Research and Director of Precision Medicine Research for Liquid Biopsies at Weill Cornell Medicine.

His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). Dr. Kasi is also recognized as an author and editor of several significant books, including “Research: What, Why, and How: A Treatise from Researchers to Researchers” and “Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies.”

His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals. He also received the Yvonne Award 2024 by OncoDaily in the “challenging the status quo” category.